Benzinga | Oct 5, 2021 05:41AM EDT

AbbVie Received FDA Approval for Venclexta for Efficacy Under NDA 208573 on Monday

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208573